FMC vs Scotts Miracle-Gro
FMC and SMG side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How FMC and SMG compare
Scotts Miracle-Gro is the larger company, worth 4.7 times as much as FMC ($3.7B against $787M).
Scotts Miracle-Gro grew revenue faster over the last twelve months (4.6% versus −22.0% for FMC).
Scotts Miracle-Gro keeps more of each dollar of sales as profit, with a net margin of 2.1% compared with −151% at FMC.
Both pay dividends: FMC yields 6.3% and Scotts Miracle-Gro 4.1%.
Scotts Miracle-Gro scores higher on the StockData Score (12 against 6 for FMC), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | FMC | SMG |
|---|---|---|
| Size and price | ||
| Market cap | $787M | $3.7B |
| Share price | $5.06 | $63.84 |
| Change, 1 year | −63.6% | 9.1% |
| Change, 5 years | −95.1% | −61.5% |
| Beta (5Y) | 0.78 | 1.30 |
| Employees | 5,500 | 5,200 |
| StockData Score | ||
| Total score | 6 | 12 (better) |
| Valuation score | 1 | 2 (better) |
| Growth score | 0 | 3 (better) |
| Performance score | 0 | 3 (better) |
| Health score | 1 | 1 |
| Dividend score | 4 (better) | 3 |
| Valuation | ||
| P/E | – | 52.8× |
| P/S | 0.3× (better) | 1.1× |
| EV/EBITDA | – | 15.2× |
| P/FCF | 2.1× (better) | 14.1× |
| FCF yield | 47.0% (better) | 7.1% |
| Fair value | – | $51.55 |
| Margin of safety | – | −23.8% |
| Growth | ||
| Revenue growth (TTM) | −22.0% | 4.6% (better) |
| Revenue growth, 5Y average | −5.7% | −3.7% (better) |
| EPS growth, 5Y average | – | −18.4% |
| Profitability | ||
| Gross margin | 22.0% | 31.8% (better) |
| Operating margin | −97.0% | 11.0% (better) |
| Net margin | −151% | 2.1% (better) |
| FCF margin | 13.1% (better) | 7.6% |
| Return on equity | −227% | – |
| Return on invested capital | −38.4% | 12.3% (better) |
| Financial health | ||
| Net debt / EBITDA | – | 5.45 |
| Interest coverage | −10.0× | 3.4× (better) |
| Current ratio | 1.66 (better) | 1.21 |
| Altman Z-score | −0.20 | 2.43 (better) |
| Piotroski F-score | 2 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | 6.3% (better) | 4.1% |
| Payout ratio | – | 209% |
| Years of dividend growth | 0 | 0 |
| Dividend growth, 5Y average | 0.22% (better) | −18.5% |
| Buyback yield | −51.2% | 0.33% (better) |
| Shareholder yield | −44.9% | 4.5% (better) |
| Ownership | ||
| Held by institutions | 82.3% | 86.5% |
| Held by insiders | 20.9% | 53.4% |
| Insider net buying, 12 months | $216K (better) | −$5.6M |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 31.2% | 19.0% |
Go deeper
- FMC stock overview
- FMC income statement
- FMC valuation and score
- SMG stock overview
- SMG income statement
- SMG valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.